Central serous chorioretinopathy following oral tadalafil

• Published in: Eye (London) Vol. 26; no. 1; pp. 168 - 169
• Main Authors: Gordon-Bennett, P, Rimmer, T
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.01.2012; Nature Publishing Group
• Subjects: Administration, Oral; Biological and medical sciences; Carbolines - administration & dosage; Carbolines - adverse effects; Central Serous Chorioretinopathy - chemically induced; Central Serous Chorioretinopathy - pathology; Correspondence; Humans; Laboratory Medicine; Male; Medical sciences; Medicine; Medicine & Public Health; Middle Aged; Miscellaneous; Ophthalmology; Pharmaceutical Sciences/Technology; Phosphodiesterase 5 Inhibitors - administration & dosage; Phosphodiesterase 5 Inhibitors - adverse effects; Retinopathies; Surgery; Surgical Oncology; Tadalafil; Visual Acuity; Retinopathy; Vasodilator agent; 3',5'-Cyclic-GMP phosphodiesterase; Enzyme; Oral administration; Enzyme inhibitor; Esterases; Uvea disease; Phosphoric diester hydrolases; Phosphodiesterase inhibitor; Phosphodiesterase 5 inhibitor; Tadalafil; Eye disease; Carboline derivatives; Central serous chorioretinopathy; Hydrolases; Ophthalmology
• ISSN: 0950-222X; 1476-5454
• DOI: 10.1038/eye.2011.250